Literature DB >> 11133373

Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes.

G Ballon1, L Ometto, E Righetti, A M Cattelan, S Masiero, M Zanchetta, L Chieco-Bianchi.   

Abstract

The effect of human immunodeficiency virus type 1 (HIV-1) on telomerase activity in peripheral blood lymphocytes (PBL) was examined. Telomerase is an enzyme that is involved in mechanisms that control cell life span and replicative potential. HIV-1 reduced telomerase activity in in vitro-infected PBL and impaired enzyme activation upon cell stimulation. Telomerase activity was significantly lower in PBL from 23 HIV-1-infected patients than in PBL from healthy donors and significantly increased during highly active antiretroviral therapy (HAART) in 10 patients who had both a virological and an immunological response and in 5 and 8 patients with a virological or an immunological response, respectively. Further analyses of fractionated cells revealed that telomerase activity increased mainly in CD4(+) lymphocytes. Overall, these findings demonstrate that HIV-1 infection down-modulates telomerase activity and suggest that both the HIV-1 decline and immunorestoration in response to HAART contribute to increased telomerase activity in CD4(+) lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11133373     DOI: 10.1086/318072

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.

Authors:  Xin Wang; Shailbala Singh; Hae-Yun Jung; Guojun Yang; Sohee Jun; K Jagannadha Sastry; Jae-Il Park
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

Review 2.  Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.

Authors:  Anna C Hearps; Genevieve E Martin; Reena Rajasuriar; Suzanne M Crowe
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

3.  HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs.

Authors:  Rita Reynoso; Matthias Wieser; Diego Ojeda; Maximilian Bönisch; Harald Kühnel; Federico Bolcic; Heribert Quendler; Johannes Grillari; Regina Grillari-Voglauer; Jorge Quarleri
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

4.  Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1.

Authors:  Dorota Piekna-Przybylska; Gaurav Sharma; Sanjay B Maggirwar; Robert A Bambara
Journal:  Cell Cycle       Date:  2017-04-07       Impact factor: 4.534

5.  Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion.

Authors:  Alejandro Gonzalez-Serna; Abhinav Ajaykumar; Izabelle Gadawski; Maria Angeles Muñoz-Fernández; Kanna Hayashi; P Richard Harrigan; Hélène C F Côté
Journal:  J Acquir Immune Defic Syndr       Date:  2017-09-01       Impact factor: 3.731

6.  Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes.

Authors:  Steven Russell Fauce; Beth D Jamieson; Allison C Chin; Ronald T Mitsuyasu; Stan T Parish; Hwee L Ng; Christina M Ramirez Kitchen; Otto O Yang; Calvin B Harley; Rita B Effros
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Authors:  Liliana Terrin; Jessica Dal Col; Enrica Rampazzo; Paola Zancai; Moreno Pedrotti; Grazia Ammirabile; Stefano Bergamin; Silvana Rizzo; Riccardo Dolcetti; Anita De Rossi
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

8.  Soluble CD163 is associated with shortened telomere length in HIV-infected patients.

Authors:  Suman Srinivasa; Kathleen V Fitch; Eva Petrow; Tricia H Burdo; Kenneth C Williams; Janet Lo; Hélène C F Cȏté; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

Review 9.  Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?

Authors:  Wasim Abbas; Muhammad Tariq; Mazhar Iqbal; Amit Kumar; Georges Herbein
Journal:  Viruses       Date:  2015-03-31       Impact factor: 5.048

10.  Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line.

Authors:  Michela Pollicita; Carolina Muscoli; Antonella Sgura; Alberto Biasin; Teresa Granato; Laura Masuelli; Vincenzo Mollace; Caterina Tanzarella; Claudio Del Duca; Paola Rodinò; Carlo Federico Perno; Stefano Aquaro
Journal:  BMC Neurosci       Date:  2009-05-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.